MetLife Inc 5.625% Series E Preferred Stock
MET.PRE
3 hedge funds and large institutions have $7.44M invested in MetLife Inc 5.625% Series E Preferred Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0.09% less ownership
Funds ownership: 1.03% → 0.95% (-0.09%)
7% less capital invested
Capital invested by funds: $7.98M → $7.44M (-$541K)
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CGH
Crossmark Global Holdings
Houston,
Texas
|
+$295K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$96 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WPP
Whalerock Point Partners
Providence,
Rhode Island
|
-$961K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CGH
1
Crossmark Global Holdings
Houston,
Texas
| $7.41M | +$295K | +12,301 | +4% |
|
|
2
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $25.9K | +$96 | +4 | +0.4% |
|
|
OP
3
ORG Partners
Roanoke,
Indiana
| $169 | – | – | – |
|
|
WPP
4
Whalerock Point Partners
Providence,
Rhode Island
| – | -$961K | -40,000 | Closed |
|
MET.PRE Hedge Fund Activity: Q2 2024 in Review
3 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) for Q2 2024, worth a combined $7.44M — down 6.8% from $7.98M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MET.PRE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Crossmark Global Holdings, adding an estimated $295K. The largest seller was Whalerock Point Partners, exiting entirely with an estimated $961K sold.
- 3 institutional investors held MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) as of Q2 2024, down from 4 in Q1 2024.
- Funds reported $7.44M of MetLife Inc 5.625% Series E Preferred Stock stock for Q2 2024, down 6.8% quarter-over-quarter.
- 0 funds opened new MetLife Inc 5.625% Series E Preferred Stock positions in Q2 2024 and 1 closed out, a net change of -1 holder.
- The largest MetLife Inc 5.625% Series E Preferred Stock buyer in Q2 2024 was Crossmark Global Holdings, an estimated $295K added.
- The largest MetLife Inc 5.625% Series E Preferred Stock seller in Q2 2024 was Whalerock Point Partners, an estimated $961K sold.
Based on aggregated 13F filings for Q2 2024.